GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 1,945 | 1,558 | 1,070 | 866 | 8,855 |
| Operating Income | -1,945 | -1,558 | -1,070 | -866 | -8,855 |
| Interest Expense | 931 | 4,658 | 638 | 635 | 560 |
| Other Income | 0 | -11,206 | 0 | 31 | -20,463 |
| Pre-tax Income | -2,876 | -17,422 | -1,708 | -1,470 | -29,878 |
| Net Income Continuous | -2,876 | -17,422 | -1,708 | -1,470 | -29,878 |
| Net Income | $-2,876 | $-17,422 | $-1,708 | $-1,470 | $-29,878 |
| EPS Basic Total Ops | -19.22 | -123.72 | -12.31 | 331.66 | -260.46 |
| EPS Basic Continuous Ops | -19.13 | -123.71 | -12.44 | -10.96 | -259.48 |
| EPS Diluted Total Ops | -19.22 | -123.72 | -12.31 | 331.66 | -260.46 |
| EPS Diluted Continuous Ops | -19.13 | -123.71 | -12.44 | -10.96 | -259.48 |
| EBITDA(a) | $-1,945 | $-1,558 | $-1,070 | $-818 | $-8,735 |